Proficio Capital Partners LLC Gilead Sciences, Inc. Transaction History

Proficio Capital Partners LLC

$892 Million
Q1 2024

A detailed history of Proficio Capital Partners LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Proficio Capital Partners LLC holds 3,168 shares of GILD stock, worth $216,691. This represents 0.03% of its overall portfolio holdings.

Number of Shares

3,168

Previous 3,094 2.39%

Holding current value

$216,691

Previous $250,000 7.2%

% of portfolio

0.03%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$71.58 - $87.29 $5,296 - $6,459	74 Added 2.39%	3,168 $232,000
Q4 2023 Feb 13, 2024	BUY	$73.27 - $83.09 $24,105 - $27,336	329 Added 11.9%	3,094 $250,000
Q3 2023 Oct 18, 2023	BUY	$73.94 - $80.67 $204,444 - $223,052	2,765 New	2,765 $207,000
Q1 2023 Apr 21, 2023	SELL	$77.31 - $88.08 $15.8 Million - $18 Million	-204,164 Reduced 98.79%	2,491 $206,000
Q1 2023 Apr 19, 2023	BUY	$77.31 - $88.08 $15.8 Million - $18 Million	204,255 Added 8510.63%	206,655 $17.1 Million

Q4 2022 Jan 30, 2023	BUY	$62.32 - $89.47 $149,568 - $214,728	2,400 New	2,400 $206,000
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $165,709 - $207,651	-2,861 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $185,621 - $210,684	2,861 New	2,861 $208,000
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $224,595 - $242,313	-3,318 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $6,093 - $6,657	96 Added 2.98%	3,318 $228,000
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $193,320 - $220,578	3,222 New	3,222 $208,000
Q3 2020 Nov 02, 2020	SELL	$62.1 - $78.08 $236,973 - $297,953	-3,816 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $22,497 - $26,124	311 Added 8.87%	3,816 $294,000
Q1 2020 May 06, 2020	BUY	$62.63 - $80.22 $219,518 - $281,171	3,505 New	3,505 $269,000
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $93,077 - $102,741	-1,489 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $65,891 - $73,889	1,065 Added 251.18%	1,489 $101,000
Q1 2019 May 13, 2019	SELL	$62.53 - $70.05 $34,266 - $38,387	-548 Reduced 56.38%	424 $28,000
Q4 2018 Feb 08, 2019	SELL	$60.54 - $79.0 $1,331 - $1,738	-22 Reduced 2.21%	972 $61,000
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $18,390 - $20,361	258 Added 35.05%	994 $77,000
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $25,497 - $29,742	-393 Reduced 34.81%	736 $52,000
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $3,860 - $4,706	53 Added 4.93%	1,129 $85,000
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $5,265 - $6,180	74 Added 7.39%	1,076 $77,000
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $72,254 - $85,640	1,002	1,002 $81,000

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $85.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Proficio Capital Partners LLC with notifications on news.

Account

Proficio Capital Partners LLC Gilead Sciences, Inc. Transaction History